GLP-1 gene delivery for the treatment of type 2 diabetes

This publication has 20 references indexed in Scilit:

• Transfection of Pancreatic-Derived β-Cells with a Minigene Encoding for Human Glucagon-Like Peptide-1 Regulates Glucose-Dependent Insulin Synthesis and Secretion
  Endocrinology, 2002
• CMV-β-Actin Promoter Directs Higher Expression from an Adeno-Associated Viral Vector in the Liver than the Cytomegalovirus or Elongation Factor 1α Promoter and Results in Therapeutic Levels of Human Factor X in Mice
  Human Gene Therapy, 2001
• Minireview: The Glucagon-Like Peptides
  Endocrinology, 2001
• Exendin-4 Decelerates Food Intake, Weight Gain, and Fat Deposition in Zucker Rats
  Endocrinology, 2000
• Near-normalisation of diurnal glucose concentrations by continuous administration of glucagon-like peptide-1 (GLP-1) in subjects with NIDDM
  Diabetologia, 1997
• Glucose-dependent action of glucagon-like peptide-1(7-37) in vivo during short- or long-term administration
  Metabolism, 1995
• Cell and Molecular Biology of the Incretin Hormones Glucagon-Like Peptide-I and Glucose-Dependent Insulin Releasing Polypeptide
  Endocrine Reviews, 1995
• Glucagon-Like Peptide-I and the Control of Insulin Secretion in the Normal State and in NIDDM
  Diabetes, 1993
• Preserved incretin activity of glucagon-like peptide 1 [7-36 amide] but not of synthetic human gastric inhibitory polypeptide in patients with type-2 diabetes mellitus.
  Journal of Clinical Investigation, 1993
• Entero-Insular Axis
  Archives of internal medicine (1960), 1969